Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-31 Purchase | 2023-09-08 5:47 pm | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 10,292 | $0.275 | $2,830 | 30,876 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-31 Option Award | 2023-09-08 5:47 pm | N/A 2028-08-31 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 20,584 | $0 | 30,876 (Indirect) | View |
| 2022-11-10 Option Award | 2022-11-10 9:51 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:53 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 868,998 | $0 | 868,998 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-13 06:03 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2021-10-12 9:23 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 0 | $0 | 527,273 (Indirect) | View |